AHR and graft versus host disease: The enzyme IDO catalyzes the rate-limiting step of tryptophan metabolism to L-kynurenine which has been shown to interact with the aryl hydrocarbon receptor (AHR) to drive Treg development and prevent GVHD (58–61).